Skip to main content

Advertisement

SpringerLink
Log in

Translocator protein and new targets for neuroinflammation

  • Review Article
  • Published:
Clinical and Translational Imaging Aims and scope Submit manuscript

Abstract

The mitochondrial translocator protein (18 kDa; TSPO) is involved in a wide array of physiological processes importantly including cholesterol transport, steroidogenesis and immunomodulation. In the central nervous system (CNS), TSPO expression regionally increases in glial cells upon brain insult with a differential pattern suggestive of cell-specific functions in inflammation and repair. These properties have made TSPO a valuable marker to assess the state, and progression of diverse neurological and psychiatric conditions, including traumatic brain injury, stroke, neurodegenerative diseases, anxiety, depression and schizophrenia. In the past years, an increasing number of radiolabeled TSPO ligands for the visualization and quantification of TSPO through positron emission tomography (PET), single-photon emission tomography (SPECT) and magnetic resonance imaging (MRI) have been developed in the pursuit of higher sensitivity and specificity for clinical applications. However, TSPO is not the only molecule holding great potential as an imaging marker of neuroinflammation; cell adhesion molecules, such as VCAM-1 and ICAM-1, the myeloperoxidase, matrix metalloproteinases, the cannabinoid receptor 2 (CB2), P2X7, cyclooxygenase 1 (COX-1), free radicals and leukocyte populations have also been subjects of study as targets to image inflammatory processes in the injured or diseased brain. In this review, we present the most relevant aspects of TSPO molecular features that fundament its imaging applications in the context of neuroinflammation, and comment on the development of imaging agents and strategies targeting TSPO as well as other molecules and cells implicated in inflammatory processes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Casellas P, Galiegue S, Basile AS (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40:475–486

    Article  CAS  PubMed  Google Scholar 

  2. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27(8):402–409

    Article  CAS  PubMed  Google Scholar 

  3. Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9(12):971–988

    Article  CAS  PubMed  Google Scholar 

  4. Liu GJ, Middleton RJ, Hatty CR, Kam WW, Chan R, Pham T, Harrison-Brown M, Dodson E, Veale K, Banati RB (2014) The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol 24(6):631–653

    Article  CAS  PubMed  Google Scholar 

  5. Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, Lee SC (2009) Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 35(3):306–328

    Article  CAS  PubMed  Google Scholar 

  6. Chen MK, Guilarte TR (2008) Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther 118(1):1–17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Fan J, Lindemann P, Feuilloley MG, Papadopoulos V (2012) Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med 12(4):369–386

    CAS  PubMed  Google Scholar 

  8. Riond J, Mattei MG, Kaghad M, Dumont X, Guillemot JC, Le Fur G, Caput D, Ferrara P (1991) Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur J Biochem 195(2):305–311

    Article  CAS  PubMed  Google Scholar 

  9. Lin D, Chang YJ, Strauss JF 3rd, Miller WL (1993) The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics 18(3):643–650

    Article  CAS  PubMed  Google Scholar 

  10. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51(4):629–650

    CAS  PubMed  Google Scholar 

  11. Veenman L, Papadopoulos V, Gavish M (2007) Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 13(23):2385–2405

    Article  CAS  PubMed  Google Scholar 

  12. Bolger GT, Mezey E, Cott J, Weissman BA, Paul SM, Skolnick P (1984) Differential regulation of ‘central’ and ‘peripheral’ benzodiazepine binding sites in the rat olfactory bulb. Eur J Pharmacol 105(1–2):143–148

    Article  CAS  PubMed  Google Scholar 

  13. Karchewski LA, Bloechlinger S, Woolf CJ (2004) Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons. Eur J Neurosci 20(3):671–683

    Article  PubMed  Google Scholar 

  14. Varga B, Markó K, Hádinger N, Jelitai M, Demeter K, Tihanyi K, Vas A, Madarász E (2009) Translocator protein (TSPO 18 kDa) is expressed by neural stem and neuronal precursor cells. Neurosci Lett 462(3):257–262

    Article  CAS  PubMed  Google Scholar 

  15. Anholt RR, Pedersen PL, De Souza EB, Snyder SH (1986) The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem 261(2):576–583

    CAS  PubMed  Google Scholar 

  16. Marangos PJ, Patel J, Boulenger JP, Clark-Rosenberg R (1982) Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol Pharmacol 22(1):26–32

    CAS  PubMed  Google Scholar 

  17. Oke BO, Suarez-Quian CA, Riond J, Ferrara P, Papadopoulos V (1992) Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex. Mol Cell Endocrinol 87(1–3):R1–R6

    Article  CAS  PubMed  Google Scholar 

  18. Jaremko L, Jaremko M, Giller K, Becker S, Zweckstetter M (2014) Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science 343(6177):1363–1366

    Article  CAS  PubMed  Google Scholar 

  19. Li F, Liu J, Zheng Y, Garavito RM, Ferguson-Miller S (2015) Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism. Science 347(6221):555–558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Li F, Liu J, Garavito RM, Ferguson-Miller S (2015) Evolving understanding of translocator protein 18 kDa (TSPO). Pharmacol Res. pii S1043–6618(15):00062–00066

    Google Scholar 

  21. Guo Y, Kalathur RC, Liu Q, Kloss B, Bruni R, Ginter C, Kloppmann E, Rost B, Hendrickson WA (2015) Protein structure. Structure and activity of tryptophan-rich TSPO proteins. Science 347(6221):551–555

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bernassau JM, Reversat JL, Ferrara P, Caput D, Lefur G (1993) A 3D model of the peripheral benzodiazepine receptor and its implication in intra mitochondrial cholesterol transport. J Mol Graph 11(4):236–244

    Article  CAS  PubMed  Google Scholar 

  23. Li H, Papadopoulos V (1998) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139(12):4991–4997

    Article  CAS  PubMed  Google Scholar 

  24. Lacapère JJ, Papadopoulos V (2003) Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 68(7–8):569–585

    Article  PubMed  CAS  Google Scholar 

  25. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V (2001) Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA 98(3):1267–1272

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Delavoie F, Li H, Hardwick M, Robert JC, Giatzakis C, Péranzi G, Yao ZX, Maccario J, Lacapère JJ, Papadopoulos V (2003) In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42(15):4506–4519

    Article  CAS  PubMed  Google Scholar 

  27. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH (1992) Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci U S A 89(8):3170–3174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Liu J, Rone MB, Papadopoulos V (2006) Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J Biol Chem 281(50):38879–38893

    Article  CAS  PubMed  Google Scholar 

  29. Galiègue S, Jbilo O, Combes T, Bribes E, Carayon P, Le Fur G, Casellas P (1999) Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J Biol Chem 274(5):2938–2952

    Article  PubMed  Google Scholar 

  30. Fan J, Liu J, Culty M, Papadopoulos V (2010) Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog Lipid Res 49(3):218–234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Rone MB, Midzak AS, Issop L, Rammouz G, Jagannathan S, Fan J, Ye X, Blonder J, Veenstra T, Papadopoulos V (2012) Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol Endocrinol 26(11):1868–1882

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Issop L, Rone MB, Papadopoulos V (2013) Organelle plasticity and interactions in cholesterol transport and steroid biosynthesis. Mol Cell Endocrinol 371(1–2):34–46

    Article  CAS  PubMed  Google Scholar 

  33. Issop L, Fan J, Lee S, Rone MB, Basu K, Mui J, Papadopoulos V (2015) Mitochondria-associated membrane formation in hormone-stimulated Leydig cell steroidogenesis: role of ATAD3. Endocrinology 156(1):334–345

    Article  PubMed  CAS  Google Scholar 

  34. Veenman L (2012) Gavish M (2012) The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Curr Mol Med 12(4):398–412

    CAS  PubMed  Google Scholar 

  35. Choi HB, Khoo C, Ryu JK, van BE, Kim SU, McLarnon JG (2002) Inhibition of lipopolysaccharide- induced cyclooxygenase-2, tumor necrosis factor-alpha and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195. J Neurochem 83:546–555

    Article  CAS  PubMed  Google Scholar 

  36. Veiga S, Carrero P, Pernia O, Azcoitia I, Garcia-Segura LM (2007) Translocator protein 18 kDa is involved in the regulation of reactive gliosis. Glia 55(14):1426–1436

    Article  PubMed  Google Scholar 

  37. Verma A, Nye JS, Snyder SH (1987) Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci U S A 84(8):2256–2260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Farges R, Joseph-Liauzun E, Shire D, Caput D, Le Fur G, Ferrara P (1994) Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864. Mol Pharmacol 46(6):1160–1167

    CAS  PubMed  Google Scholar 

  39. Midzak A, Akula N, Lecanu L, Papadopoulos V (2011) Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. J Biol Chem 286(11):9875–9887

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Midzak AS, Akula N, Rone MB, Papadopoulos V (2015) Computational modeling and biological validation of novel non-steroidal ligands for the cholesterol recognition/interaction amino acid consensus (CRAC) motif of the mitochondrial translocator protein (TSPO). Pharmacol Res. pii: S1043-6618(15)00064-X

  41. Scarf AM, Luus C, Da Pozzo E, Selleri S, Guarino C, Martini C, Ittner LM, Kassiou M (2012) Evidence for complex binding profiles and species differences at the translocator protein (TSPO) (18 kDa). Curr Mol Med 12(4):488–493

    CAS  PubMed  Google Scholar 

  42. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, Rhodes C, Pulford DJ, Bennacef I, Parker CA, StJean PL, Cardon LR, Mooser VE, Matthews PM, Rabiner EA, Rubio JP (2012) An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 32(1):1–5

    Article  CAS  PubMed  Google Scholar 

  43. Kreisl WC, Jenko KJ, Hines CS, Lyoo CH, Corona W, Morse CL, Zoghbi SS, Hyde T, Kleinman JE, Pike VW, McMahon FJ, Innis RB; Biomarkers Consortium PET Radioligand Project Team (2013) A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab 33(1):53–58

    Article  CAS  Google Scholar 

  44. Costa B, Pini S, Gabelloni P, Da Pozzo E, Abelli M, Lari L, Preve M, Lucacchini A, Cassano GB, Martini C (2009) The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology 150(12):5438–5445

    Article  CAS  PubMed  Google Scholar 

  45. Jaremko M, Jaremko L, Giller K, Becker S, Zweckstetter M (2015) Structural integrity of the A147T polymorph of mammalian TSPO. ChemBioChem. doi:10.1002/cbic.201500217

    PubMed  Google Scholar 

  46. Li F, Liu J, Valls L, Hiser C, Ferguson-Miller S (2015) Identification of a key cholesterol binding enhancement motif in translocator protein 18 kDa. Biochemistry 54(7):1441–1443

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Romeo E, Auta J, Kozikowski AP, Ma D, Papadopoulos V, Puia G, Costa E, Guidotti A (1992) 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J Pharmacol Exp Ther 262(3):971–978

    CAS  PubMed  Google Scholar 

  48. Rupprecht R, Rammes G, Eser D, Baghai TC, Schüle C, Nothdurfter C, Troxler T, Gentsch C, Kalkman HO, Chaperon F, Uzunov V, McAllister KH, Bertaina-Anglade V, La Rochelle CD, Tuerck D, Floesser A, Kiese B, Schumacher M, Landgraf R, Holsboer F, Kucher K (2009) Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325(5939):490–493

    Article  CAS  PubMed  Google Scholar 

  49. Gut P, Zweckstetter M, Banati RB (2015) Lost in translocation: the functions of the 18-kD translocator protein. Trends Endocrinol Metab. pii S1043–2760(15):00080–00086

    Google Scholar 

  50. Costa B, Pini S, Abelli M, Gabelloni P, Da Pozzo E, Chelli B, Calugi S, Lari L, Cardini A, Lucacchini A, Cassano GB, Martini C (2012) Role of translocator protein (18 kDa) in adult separation anxiety and attachment style in patients with depression. Curr Mol Med 12(4):483–487

    CAS  PubMed  Google Scholar 

  51. Colasanti A, Owen DR, Grozeva D, Rabiner EA, Matthews PM, Craddock N, Young AH (2013) Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa Translocator Protein (TSPO). Psychoneuroendocrinology 38(11):2826–2829

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Fan J, Rone MB, Papadopoulos V (2009) Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis. J Biol Chem 284(44):30484–30497

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Itzhak Y, Norenberg MD (1994) Attenuation of ammonia toxicity in mice by PK 11195 and pregnenolone sulfate. Neurosci Lett 182:251–254

    Article  CAS  PubMed  Google Scholar 

  54. Veenman L, Leschiner S, Spanier I, Weisinger G, Weizman A, Gavish M (2002) PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J Neurochem 80(5):917–927

    Article  CAS  PubMed  Google Scholar 

  55. Ryu JK, Choi HB, McLarnon JG (2005) Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum. Neurobiol Dis 20:550–561

    Article  CAS  PubMed  Google Scholar 

  56. Ji B, Maeda J, Sawada M, Ono M, Okauchi T, Inaji M, Zhang MR, Suzuki K, Ando K, Staufenbiel M, Trojanowski JQ, Lee VM, Higuchi M, Suhara T (2008) Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer’s and other CNS pathologies. J Neurosci 28(47):12255–12267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Gavish M, Weizman R (1997) Role of peripheral-type benzodiazepine receptors in steroidogenesis. Clin Neuropharmacol 20:473–481

    Article  CAS  PubMed  Google Scholar 

  58. Girard C, Liu S, Adams D, Lacroix C, Sinéus M, Boucher C, Papadopoulos V, Rupprecht R, Schumacher M, Groyer G (2012) Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. J Neuroendocrinol 24(1):71–81

    Article  CAS  PubMed  Google Scholar 

  59. Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V (2014) Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 155(1):89–97

    Article  PubMed  CAS  Google Scholar 

  60. Tu LN, Morohaku K, Manna PR, Pelton SH, Butler WR, Stocco DM, Selvaraj V (2014) Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J Biol Chem 289(40):27444–27454

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Šileikytė J, Blachly-Dyson E, Sewell R, Carpi A, Menabò R, Di Lisa F, Ricchelli F, Bernardi P, Forte M (2014) Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor [Translocator Protein of 18 kDa (TSPO)]. J Biol Chem 289(20):13769–13781

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  62. Fan J, Campioli E, Midzak A, Culty M, Papadopoulos V (2015) Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation. Proc Natl Acad Sci U S A 112(23):7261–7266

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Raghavan A, Sheiko T, Graham BH, Craigen WJ (1818) Voltage-dependant anion channels: novel insights into isoform function through genetic models. Biochim Biophys Acta 6:1477–1485

    Google Scholar 

  64. Papadopoulos V, Aghazadeh Y, Fan J, Campioli E, Zirkin B, Midzak A (2015) Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis. Mol Cell Endocrinol 408:90–98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Costa E, Auta J, Guidotti A, Korneyev A, Romeo E (1994) The pharmacology of neurosteroidogenesis. J Steroid Biochem Mol Biol 49(4–6):385–389

    Article  CAS  PubMed  Google Scholar 

  66. Papadopoulos V, Lecanu L (2009) Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma. Exp Neurol 219(1):53–57

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Kuhlmann AC, Guilarte TR (2000) Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 74(4):1694–1704

    Article  CAS  PubMed  Google Scholar 

  68. Chen MK, Guilarte TR (2006) Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. Toxicol Sci 91(2):532–539

    Article  CAS  PubMed  Google Scholar 

  69. Wang M, Gao M, Hutchins GD, Zheng QH (2009) Synthesis of [11C]FEDAA1106 as a new PET imaging probe of peripheral benzodiazepine receptor expression. Eur J Med Chem 44(6):2748–2753

    Article  CAS  PubMed  Google Scholar 

  70. Doorduin J, Klein HC, Dierckx RA, James M, Kassiou M, de Vries EF (2009) [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis. Mol Imaging Biol 11(6):386–398

    Article  PubMed  PubMed Central  Google Scholar 

  71. Chaki S, Funakoshi T, Yoshikawa R, Okuyama S, Okubo T, Nakazato A, Nagamine M, Tomisawa K (1999) Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors. Eur J Pharmacol 371(2–3):197–204

    Article  CAS  PubMed  Google Scholar 

  72. Zhang MR, Maeda J, Ogawa M, Noguchi J, Ito T, Yoshida Y, Okauchi T, Obayashi S, Suhara T, Suzuki K (2004) Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. J Med Chem 47(9):2228–2235

    Article  CAS  PubMed  Google Scholar 

  73. Imaizumi M, Briard E, Zoghbi SS, Gourley JP, Hong J, Fujimura Y, Pike VW, Innis RB, Fujita M (2008) Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage 39(3):1289–1298

    Article  PubMed  Google Scholar 

  74. Fookes CJ, Pham TQ, Mattner F, Greguric I, Loc’h C, Liu X, Berghofer P, Shepherd R, Gregoire MC, Katsifis A (2008) Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. J Med Chem 51(13):3700–3712

    Article  CAS  PubMed  Google Scholar 

  75. Zhang MR, Kumata K, Maeda J, Yanamoto K, Hatori A, Okada M, Higuchi M, Obayashi S, Suhara T, Suzuki K (2007) 11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain. J Nucl Med 48(11):1853–1861

    Article  CAS  PubMed  Google Scholar 

  76. Mattner F, Mardon K, Katsifis A (2008) Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS). Eur J Nucl Med Mol Imaging 35(4):779–789

    Article  CAS  PubMed  Google Scholar 

  77. Gulyás B, Vas A, Tóth M, Takano A, Varrone A, Cselényi Z, Schain M, Mattsson P, Halldin C (2011) Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine. Neuroimage 56(3):1111–1121

    Article  PubMed  CAS  Google Scholar 

  78. Verleye M, Akwa Y, Liere P, Ladurelle N, Pianos A, Eychenne B, Schumacher M, Gillardin JM (2005) The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain. Pharmacol Biochem Behav 82(4):712–720

    Article  CAS  PubMed  Google Scholar 

  79. Girard C, Liu S, Cadepond F, Adams D, Lacroix C, Verleye M, Gillardin JM, Baulieu EE, Schumacher M, Schweizer-Groyer G (2008) Etifoxine improves peripheral nerve regeneration and functional recovery. Proc Natl Acad Sci USA 105(51):20505–20510

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Lartey FM, Ahn GO, Shen B, Cord KT, Smith T, Chua JY, Rosenblum S, Liu H, James ML, Chernikova S, Lee SW, Pisani LJ, Tirouvanziam R, Chen JW, Palmer TD, Chin FT, Guzman R, Graves EE, Loo BW Jr (2014) PET imaging of stroke-induced neuroinflammation in mice using [18F]PBR06. Mol Imaging Biol 16(1):109–117

    Article  PubMed  Google Scholar 

  81. Kumar A, Muzik O, Shandal V, Chugani D, Chakraborty P, Chugani HT (2012) Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11)C-[R]-PK11195 PET. J Neuroinflammation 9:232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Suridjan I, Rusjan PM, Voineskos AN, Selvanathan T, Setiawan E, Strafella AP, Wilson AA, Meyer JH, Houle S, Mizrahi R (2014) Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18 kDa (TSPO) radioligand, [(18)F]-FEPPA. Neuroimage 84:868–875

    Article  CAS  PubMed  Google Scholar 

  83. Winkeler A, Boisgard R, Martin A, Tavitian B (2010) Radioisotopic imaging of neuroinflammation. J Nucl Med 51(1):1–4

    Article  CAS  PubMed  Google Scholar 

  84. Ching AS, Kuhnast B, Damont A, Roeda D, Tavitian B, Dollé F (2012) Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases. Insights Imaging 3(1):111–119

    Article  PubMed  Google Scholar 

  85. Varley J, Brooks DJ, Edison P (2014) Imaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions. Alzheimers Dement. pii S1552–5260(14):02820–02829

    Google Scholar 

  86. Varrone A, Mattson P, Forsberg A, Takano A, Nag S, Gulyás B, Borg J, Boellaard R, al-Tawil N, eriksdotter M, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Lammertsma AA, Halldin C (2013) In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients. Eur J Nucl Med Mol Imaging 40(6):921–931

    Article  CAS  PubMed  Google Scholar 

  87. Schüle C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, Rupprecht R (2011) Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience 191:55–77

    Article  PubMed  CAS  Google Scholar 

  88. Da Pozzo E, Costa B, Martini C (2012) Translocator protein (TSPO) and neurosteroids: implications in psychiatric disorders. Curr Mol Med 12(4):426–442

    PubMed  Google Scholar 

  89. Batarseh A, Papadopoulos V (2010) Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol Cell Endocrinol 327(1–2):1–12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Wu C, Yue X, Lang L, Kiesewetter DO, Li F, Zhu Z, Niu G, Chen X (2014) Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors. Theranostics 4(5):546–555

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  91. Daniele S, Taliani S, Da Pozzo E, Giacomelli C, Costa B, Trincavelli ML, Rossi L, La Pietra V, Barresi E, Carotenuto A, Limatola A, Lamberti A, Marinelli L, Novellino E, Da Settimo F, Martini C (2014) Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma. Sci Rep 4:4749

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  92. Su Z, Roncaroli F, Durrenberger PF, Coope DJ, Karabatsou K, Hinz R, Thompson G, Turkheimer FE, Janczar K, Du Plessis D, Brodbelt A, Jackson A, Gerhard A, Herholz K (2015) The 18-kDa mitochondrial translocator protein in human gliomas: an 11C-(R)PK11195 PET imaging and neuropathology study. J Nucl Med 56(4):512–517

    Article  CAS  PubMed  Google Scholar 

  93. Mills C, Makwana M, Wallace A, Benn S, Schmidt H, Tegeder I, Costigan M, Brown RH Jr, Raivich G, Woolf CJ (2008) Ro5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats. Eur J Neurosci 27(4):937–946

    Article  PubMed  Google Scholar 

  94. Giatti S, Pesaresi M, Cavaletti G, Bianchi R, Carozzi V, Lombardi R, Maschi O, Lauria G, Garcia-Segura LM, Caruso D, Melcangi RC (2009) Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience 164(2):520–529

    Article  CAS  PubMed  Google Scholar 

  95. Miller TR, Wetter JB, Jarvis MF, Bitner RS (2013) Spinal microglial activation in rat models of neuropathic and osteoarthritic pain: an autoradiographic study using [3H]PK11195. Eur J Pain 17(5):692–703

    Article  CAS  PubMed  Google Scholar 

  96. Liu X, Li W, Dai L, Zhang T, Xia W, Liu H, Ma K, Xu J, Jin Y (2014) Early repeated administration of progesterone improves the recovery of neuropathic pain and modulates spinal 18 kDa-translocator protein (TSPO) expression. J Steroid Biochem Mol Biol 143:130–140

    Article  CAS  PubMed  Google Scholar 

  97. Schumacher M, Sitruk-Ware R, De Nicola AF (2008) Progesterone and progestins: neuroprotection and myelin repair. Curr Opin Pharmacol 8(6):740–746

    Article  CAS  PubMed  Google Scholar 

  98. Man S, Ubogu EE, Ransohoff RM (2007) Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol 17(2):243–250

    Article  CAS  PubMed  Google Scholar 

  99. Sipkins DA, Gijbels K, Tropper FD, Bednarski M, Li KC, Steinman L (2000) ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuroimmunol 104(1):1–9

    Article  CAS  PubMed  Google Scholar 

  100. McAteer MA, Sibson NR, von Zur Muhlen C, Schneider JE, Lowe AS, Warrick N, Channon KM, Anthony DC, Choudhury RP (2007) In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med 13(10):1253–1258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Montagne A, Gauberti M, Macrez R, Jullienne A, Briens A, Raynaud JS, Louin G, Buisson A, Haelewyn B, Docagne F, Defer G, Vivien D, Maubert E (2012) Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders. Neuroimage 63(2):760–770

    Article  PubMed  Google Scholar 

  102. Deddens LH, van Tilborg GA, van der Toorn A, van der Marel K, Paulis LE, van Bloois L, Storm G, Strijkers GJ, Mulder WJ, de Vries HE, Dijkhuizen RM (2013) MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent. Mol Imaging Biol 15(4):411–422

    Article  PubMed  Google Scholar 

  103. van Kasteren SI, Campbell SJ, Serres S, Anthony DC, Sibson NR, Davis BG (2009) Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc Natl Acad Sci U S A 106(1):18–23

    Article  PubMed  Google Scholar 

  104. Yokoyama H, Itoh O, Aoyama M, Obara H, Ohya H, Kamada H (2002) In vivo temporal EPR imaging of the brain of rats by using two types of blood-brain barrier-permeable nitroxide radicals. Magn Reson Imaging 20(3):277–284

    Article  CAS  PubMed  Google Scholar 

  105. Lee MC, Shoji H, Miyazaki H, Yoshino F, Hori N, Miyake S, Ikeda Y, Anzai K, Ozawa T (2003) Measurement of oxidative stress in the rodent brain using computerized electron spin resonance tomography. Magn Reson Med Sci 2(2):79–84

    Article  PubMed  Google Scholar 

  106. Yamato M, Shiba T, Yamada K, Watanabe T, Utsumi H (2009) Noninvasive assessment of the brain redox status after transient middle cerebral artery occlusion using Overhauser-enhanced magnetic resonance imaging. J Cereb Blood Flow Metab 29(10):1655–1664

    Article  PubMed  Google Scholar 

  107. Yamato M, Shiba T, Naganuma T, Ichikawa K, Utsumi H, Yamada K (2011) Overhauser-enhanced magnetic resonance imaging characterization of mitochondria functional changes in the 6-hydroxydopamine rat model. Neurochem Int 59(6):804–811

    Article  CAS  PubMed  Google Scholar 

  108. Chen JW, Querol Sans M, Bogdanov A Jr, Weissleder R (2006) Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 240(2):473–481

    Article  PubMed  Google Scholar 

  109. Zhang N, Francis KP, Prakash A, Ansaldi D (2013) Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles. Nat Med 19(4):500–505

    Article  CAS  PubMed  Google Scholar 

  110. Alshetaiwi HS, Balivada S, Shrestha TB, Pyle M, Basel MT, Bossmann SH, Troyer DL (2013) Luminol-based bioluminescence imaging of mouse mammary tumors. J Photochem Photobiol B 127:223–228

    Article  CAS  PubMed  Google Scholar 

  111. Tseng JC, Kung AL (2013) In vivo imaging method to distinguish acute and chronic inflammation. J Vis Exp. doi:10.3791/50690

    PubMed  PubMed Central  Google Scholar 

  112. Yong VW (2005) Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6(12):931–944

    Article  CAS  PubMed  Google Scholar 

  113. Klohs J, Baeva N, Steinbrink J, Bourayou R, Boettcher C, Royl G, Megow D, Dirnagl U, Priller J, Wunder A (2009) In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia. J Cereb Blood Flow Metab 29(7):1284–1292

    Article  CAS  PubMed  Google Scholar 

  114. Liu N, Shang J, Tian F, Nishi H, Abe K (2011) In vivo optical imaging for evaluating the efficacy of edaravone after transient cerebral ischemia in mice. Brain Res 1397:66–75

    Article  CAS  PubMed  Google Scholar 

  115. Barber PA, Rushforth D, Agrawal S, Tuor UI (2012) Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia. BMC Neurosci 13:76

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Schwenck J, Griessinger CM, Fuchs K, Bukala D, Bauer N, Eichner M, Röcken M, Pichler BJ, Kneilling M (2014) In vivo optical imaging of matrix metalloproteinase activity detects acute and chronic contact hypersensitivity reactions and enables monitoring of the antiinflammatory effects of N-acetylcysteine. Mol Imaging. doi:10.2310/7290.2014.00044

    PubMed  Google Scholar 

  117. Horti AG, Gao Y, Ravert HT, Finley P, Valentine H, Wong DF, Endres CJ, Savonenko AV, Dannals RF (2010) Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). Bioorg Med Chem 18(14):5202–5207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Evens N, Muccioli GG, Houbrechts N, Lambert DM, Verbruggen AM, Van Laere K, Bormans GM (2009) Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging. Nucl Med Biol 36(4):455–465

    Article  CAS  PubMed  Google Scholar 

  119. Evens N, Vandeputte C, Muccioli GG, Lambert DM, Baekelandt V, Verbruggen AM, Debyser Z, Van Laere K, Bormans GM (2011) Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging. Bioorg Med Chem 19(15):4499–4505

    Article  CAS  PubMed  Google Scholar 

  120. Evens N, Vandeputte C, Coolen C, Janssen P, Sciot R, Baekelandt V, Verbruggen AM, Debyser Z, Van Laere K, Bormans GM (2012) Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer. Nucl Med Biol 39(3):389–399

    Article  CAS  PubMed  Google Scholar 

  121. Turkman N, Shavrin A, Paolillo V, Yeh HH, Flores L, Soghomonian S, Rabinovich B, Volgin A, Gelovani J, Alauddin M (2012) Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor. Nucl Med Biol 39(4):593–600

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Mu L, Slavik R, Müller A, Popaj K, Cermak S, Weber M, Schibli R, Krämer SD, Ametamey SM (2014) Synthesis and preliminary evaluation of a 2-oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor. Pharmaceuticals (Basel) 7(3):339–352

    Article  CAS  Google Scholar 

  123. Saccomanni G, Pascali G, Carlo SD, Panetta D, De Simone M, Bertini S, Burchielli S, Digiacomo M, Macchia M, Manera C, Salvadori PA (2015) Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor. Bioorg Med Chem Lett 25(12):2532–2535

    Article  CAS  PubMed  Google Scholar 

  124. Slavik R, Grether U, Müller Herde A, Gobbi L, Fingerle J, Ullmer C, Krämer SD, Schibli R, Mu L, Ametamey SM (2015) Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor. J Med Chem 58(10):4266–4277

    Article  CAS  PubMed  Google Scholar 

  125. Ling X, Zhang S, Shao P, Li W, Yang L, Ding Y, Xu C, Stella N, Bai M (2015) A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1R. Biomaterials 57:169–178

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Zhang S, Shao P, Ling X, Yang L, Hou W, Thorne SH, Beaino W, Anderson CJ, Ding Y, Bai M (2015) In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe. Am J Nucl Med Mol Imaging 5(3):246–258

    CAS  PubMed  PubMed Central  Google Scholar 

  127. Eaton VL, Vasquez KO, Goings GE, Hunter ZN, Peterson JD, Miller SD (2013) Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo. J Neuroinflammation 10:138

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  128. Ohnishi A, Senda M, Yamane T, Sasaki M, Mikami T, Nishio T, Ikari Y, Nishida H, Shukuri M, Takashima T, Mawatari A (2014) Doi H, Watanabe Y, Onoe H Human whole-body biodistribution and dosimetry of a new PET tracer, [(11)C]ketoprofen methyl ester, for imagings of neuroinflammation. Nucl Med Biol 41(7):594–599

    Article  CAS  PubMed  Google Scholar 

  129. Weisman GA, Camden JM, Peterson TS, Ajit D, Woods LT, Erb L (2012) P2 receptors for extracellular nucleotides in the central nervous system: role of P2X7 and P2Y2 receptor interactions in neuroinflammation. Mol Neurobiol 46(1):96–113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. Janssen B, Vugts DJ, Funke U, Spaans A, Schuit RC, Kooijman E, Rongen M, Perk LR, Lammertsma AA, Windhorst AD (2014) Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C]A-740003 as a novel tracer of neuroinflammation. J Labelled Comp Radiopharm 57(8):509–516

    Article  CAS  PubMed  Google Scholar 

  131. Kawamura K, Kimura Y, Yui J, Wakizaka H, Yamasaki T, Hatori A, Kumata K, Fujinaga M, Yoshida Y, Ogawa M, Nengaki N, Fukumura T, Zhang MR (2012) PET study using [11C]FTIMD with ultra-high specific activity to evaluate I2-imidazoline receptors binding in rat brains. Nucl Med Biol 39(2):199–206

    Article  CAS  PubMed  Google Scholar 

  132. Antunes IF, Doorduin J, Haisma HJ, Elsinga PH, van Waarde A, Willemsen AT, Dierckx RA, de Vries EF (2012) 18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation. J Nucl Med 53(3):451–458

    Article  CAS  PubMed  Google Scholar 

  133. Jacobs AH, Tavitian B, INMiND consortium (2012) Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab 32(7):1393–1415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Pulli B, Chen JW (2014) Imaging Neuroinflammation—from Bench to Bedside. J Clin Cell Immunol 5:226. doi:10.4172/2155-9899.1000226

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by funds of the INMiND Project of the European Union to M.T.H. and a grant from the Canadian Institutes of Health Research (MOP125983) as well as a Canada Research Chair in Biochemical Pharmacology to V.P.

Author information

Authors and Affiliations

  1. Clinical Neuroscience Unit, Department of Neurology, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany

    Marisol Herrera-Rivero & Michael T. Heneka

  2. German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany

    Michael T. Heneka

  3. Research Institute of the McGill University Health Centre, Montreal, QC, H4A 3J1, Canada

    Vassilios Papadopoulos

  4. Department of Medicine, McGill University, Montreal, QC, H4A 3J1, Canada

    Vassilios Papadopoulos

  5. Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, H3G 1Y6, Canada

    Vassilios Papadopoulos

  6. Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada

    Vassilios Papadopoulos

Authors
  1. Marisol Herrera-Rivero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael T. Heneka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vassilios Papadopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael T. Heneka.

Ethics declarations

Conflict of interest

M Herrera-Rivero and MT Heneka declare no conflict of interest. V Papadopoulos is named inventor in patents and patent applications reporting TSPO drug ligands.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herrera-Rivero, M., Heneka, M.T. & Papadopoulos, V. Translocator protein and new targets for neuroinflammation. Clin Transl Imaging 3, 391–402 (2015). https://doi.org/10.1007/s40336-015-0151-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40336-015-0151-x

Keywords

Search

Navigation